Our data confirm that, although significant placebo and nocebo effects were found on days 1 and 8, the nocebo effect was consistently stronger. Both effects were primarily influenced by the most ...

nwhcn.org.au) Objective—To determine whether minimum clinically significant difference in visual analogue scale (VAS) pain score varies according ... for the “moderate pain” group 14 mm (95%CI 10 mm ...

Please provide your email address to receive an email when new articles are posted on . Miebo produced symptom relief within 60 minutes after a single administration on the first day. A researcher ...

Introduction Interstitial lung disease (ILD) patients may develop a progressive phenotype usually characterised by ...

Objective The objective of this study is to evaluate the comparative benefits and harms of opioids and cannabis for medical use for chronic non-cancer pain. Design Systematic review and network ...

Both interventions were conducted at a distance of 15–30 cm for 10 min. Key physiological and subjective measures, including heart rate, respiratory rate, blood pressure, blood oxygen saturation, ...

followed by a continuous infusion at 10 mL/h for the first 24 hours. Study Objectives The primary aim was to assess the number of rescue analgesic (RA) doses required within the first 24 hours ...

The primary outcome measures encompassed pain intensity via the visual analogue scale (VAS), cervical active ROM ... of the VAS was defined as a decrease of greater than or equal to 10 mm, and changes ...

Rupioid plaques are small (2–5 cm in diameter) and highly hyperkeratotic ... derived from the PASI P—Psychosocial disability: measured as 0–10 on a visual analogue scale I—Interventions: a cumulative ...